AGP Limited (AGP): Profitability prospects to remain attractive; Buy - By JS Research
Apr 25 2025
JS Global Capital
- We preview 1QCY25 earnings for AGP Limited (AGP), expecting the company to post consolidated earnings of Rs861mn, up 2.2x YoY, taking EPS to Rs3.07. The significant rise in profitability is primarily driven by rise in drug prices with higher nonessential mix, increase in sales volume, and lower finance costs.
- On QoQ basis, profitability is likely to witness a dip owing to relatively lower margins (compared to the previous quarter with peak sales volumes/ margins). Accordingly, we expect gross margins to hover around 59% in 1QCY25, down 5ppts QoQ.
- While seasonal factors weighed on quarterly margins, annual gross margins are expected to remain stable, underpinned by a higher non-essential mix (>60%), softer API prices, and the full internalization of the Viatris portfolio by end-CY25.
Current:
Open:
Volume:
Change: ()
High:
Low:
52 Week High:
Vol Avg(12 m):
Free Float:
52 Week Low:
Market Cap:
Total Share:
Relative Strength Index (RSI)
RSI:
MACD Signals
MACD DAILY:
MACD WEEKLY:
Simple Moving Avg (SMA)
SMA(10):
SMA(30):
SMA(60):
SMA(200):
Performance
One Month:
Three Months:
Six Months:
Twelve Months:
Support & Resistance
Support 1:
Resistance 1:
Support 2:
Resistance 2:
High & Lows
Period
High
Low